Cargando…
Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species
BACKGROUND AND AIM: Acute myeloid leukemia (AML), initiated and maintained by leukemia stem cells (LSCs), is often relapsed or refractory to therapy. The present study aimed at assessing the effects of nanozyme-like Fe(3)O(4) nanoparticles (IONPs) combined with cytosine arabinoside (Ara-C) on LSCs i...
Autores principales: | Dou, Jun, Li, Luoyang, Guo, Mei, Mei, Feng, Zheng, Danfeng, Xu, Hui, Xue, Rui, Bao, Xueyang, Zhao, Fengshu, Zhang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900778/ https://www.ncbi.nlm.nih.gov/pubmed/33633448 http://dx.doi.org/10.2147/IJN.S278885 |
Ejemplares similares
-
Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo
por: Wu, Hongzhang, et al.
Publicado: (2020) -
Clinical trial of low dose cytosine arabinoside in the treatment of acute promyelocytic leukemia.
por: Sung, K. W., et al.
Publicado: (1997) -
A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979) -
Enhancement of the Cytotoxicity of Cytosine Arabinoside by Interleukin‐3
por: Tanaka, Masao
Publicado: (1992) -
Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia
por: Patel, Sachit A., et al.
Publicado: (2014)